136 related articles for article (PubMed ID: 23030608)
21. Obituary: Toshio Fujita, QSAR pioneer.
Akamatsu M; Oprea TI
J Comput Aided Mol Des; 2017 Nov; 31(11):959-960. PubMed ID: 29119351
[TBL] [Abstract][Full Text] [Related]
22. Editorial: Topological and electrotopological descriptors of molecules: fundamental principles and applications to computer aided molecular design - Part I.
Basak SC; Restrepo G
Curr Comput Aided Drug Des; 2012 Jun; 8(2):83-4. PubMed ID: 22497464
[No Abstract] [Full Text] [Related]
23. Optimizing the use of open-source software applications in drug discovery.
Geldenhuys WJ; Gaasch KE; Watson M; Allen DD; Van der Schyf CJ
Drug Discov Today; 2006 Feb; 11(3-4):127-32. PubMed ID: 16533710
[TBL] [Abstract][Full Text] [Related]
24. Parsimony Principle and its Proper use/ Application in Computer-assisted Drug Design and QSAR.
Basak SC; Vracko MG
Curr Comput Aided Drug Des; 2020; 16(1):1-5. PubMed ID: 31934837
[No Abstract] [Full Text] [Related]
25. Biomolecular recognition of antagonists by α7 nicotinic acetylcholine receptor: Antagonistic mechanism and structure-activity relationships studies.
Peng W; Ding F
Eur J Pharm Sci; 2015 Aug; 76():119-32. PubMed ID: 25963024
[TBL] [Abstract][Full Text] [Related]
26. Towards a MIP-based alignment and docking in computer-aided drug design.
Barbany M; Gutiérrez-de-Terán H; Sanz F; Villà-Freixa J
Proteins; 2004 Aug; 56(3):585-94. PubMed ID: 15229890
[TBL] [Abstract][Full Text] [Related]
27. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
28. Editorial: Computer Aided Structure-based Lead Optimization.
Beuming T; Shi L
Curr Top Med Chem; 2017; 17(23):2575-2576. PubMed ID: 28889794
[No Abstract] [Full Text] [Related]
29. QSAR studies on human 5alpha-reductase inhibitors: unsaturated 3-carboxysteroids.
Aggarwal S; Thareja S; Verma A; Bhardwaj TR; Kumar M
Acta Pol Pharm; 2011; 68(3):447-52. PubMed ID: 21648201
[No Abstract] [Full Text] [Related]
30. Outliers in SAR and QSAR: 2. Is a flexible binding site a possible source of outliers?
Kim KH
J Comput Aided Mol Des; 2007 Aug; 21(8):421-35. PubMed ID: 17646926
[TBL] [Abstract][Full Text] [Related]
31. Applications of computer-aided approaches in the development of hepatitis C antiviral agents.
Ganesan A; Barakat K
Expert Opin Drug Discov; 2017 Apr; 12(4):407-425. PubMed ID: 28164720
[TBL] [Abstract][Full Text] [Related]
32. Computer-aided scaffold hopping to identify a novel series of casein kinase 1 delta (CK1d) inhibitors for amyotrophic lateral sclerosis.
Makhuri FR; Ghasemi JB
Eur J Pharm Sci; 2015 Oct; 78():151-62. PubMed ID: 26206296
[TBL] [Abstract][Full Text] [Related]
33. Editorial: Multi-Target in Computer-Aided Drug Design Studies.
Scotti L; Scotti MT
Curr Drug Targets; 2017; 18(5):498-499. PubMed ID: 28270060
[No Abstract] [Full Text] [Related]
34. The present utility and future potential for medicinal chemistry of QSAR/QSPR with whole molecule descriptors.
Katritzky AR; Fara DC; Petrukhin RO; Tatham DB; Maran U; Lomaka A; Karelson M
Curr Top Med Chem; 2002 Dec; 2(12):1333-56. PubMed ID: 12470284
[TBL] [Abstract][Full Text] [Related]
35. Computational design of novel fullerene analogues as potential HIV-1 PR inhibitors: Analysis of the binding interactions between fullerene inhibitors and HIV-1 PR residues using 3D QSAR, molecular docking and molecular dynamics simulations.
Durdagi S; Mavromoustakos T; Chronakis N; Papadopoulos MG
Bioorg Med Chem; 2008 Dec; 16(23):9957-74. PubMed ID: 18996019
[TBL] [Abstract][Full Text] [Related]
36. Methods for building quantitative structure-activity relationship (QSAR) descriptors and predictive models for computer-aided design of antimicrobial peptides.
Taboureau O
Methods Mol Biol; 2010; 618():77-86. PubMed ID: 20094859
[TBL] [Abstract][Full Text] [Related]
37. Targeting of AMP-activated protein kinase: prospects for computer-aided drug design.
Kim J; Yang G; Ha J
Expert Opin Drug Discov; 2017 Jan; 12(1):47-59. PubMed ID: 27797589
[TBL] [Abstract][Full Text] [Related]
38. QSAR studies in the discovery of novel type-II diabetic therapies.
Abuhammad A; Taha MO
Expert Opin Drug Discov; 2016; 11(2):197-214. PubMed ID: 26558613
[TBL] [Abstract][Full Text] [Related]
39. Computational Study and Modified Design of Selective Dopamine D3 Receptor Agonists.
Duan X; Zhang X; Xu B; Wang F; Lei M
Chem Biol Drug Des; 2016 Jul; 88(1):142-54. PubMed ID: 26851125
[TBL] [Abstract][Full Text] [Related]
40. Rational design of methicillin resistance staphylococcus aureus inhibitors through 3D-QSAR, molecular docking and molecular dynamics simulations.
Ballu S; Itteboina R; Sivan SK; Manga V
Comput Biol Chem; 2018 Apr; 73():95-104. PubMed ID: 29475176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
